NetScientific Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
35
- Portfolio
-
16
- Exits
-
11
NetScientific General Information
Description
Founded in 2012, NetScientific plc (AIM: NSCI) is an investment and commercialization group with an international portfolio of innovative life science, sustainability, and technology companies based in London, United Kingdom. The firm identifies, invests in, and builds high-growth companies in the UK and internationally.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 20 Saint Andrew Street
- London EC4A 3AG
- England, United Kingdom
+44 020 0000 0000
NetScientific Investments & Acquisitions (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Fox Biosystems | 13-Dec-2022 | Later Stage VC | 00.000 | Other Devices and Supplies | Generating Revenue | |
| 000000 00000000000 | 29-Nov-2022 | 00000 00000 | 00.000 | Wireless Communications Equipment | Generating Revenue/Not Profitable | 00000 00000 00.0 |
| 0-000 | 14-Jun-2022 | 00000 00000 | 00.000 | Other Commercial Products | Generating Revenue | |
| 0-000 | 22-Dec-2021 | 00000 00000 | 00.000 | Other Commercial Products | Generating Revenue | |
| 00000000 | 20-Dec-2021 | 000000000000 | 00000 | Private Equity | Generating Revenue | 00000 00000 00.0 |
| 0000000 | 15-Dec-2021 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 00000 00.0 |
| 0000000 | 01-Dec-2021 | 00000 00000 | Electronic Equipment and Instruments | Generating Revenue | ||
| 00000000 000000000 | 01-Dec-2021 | 00000 00000 | Specialty Chemicals | Generating Revenue | ||
| Sofant Technologies | 27-Apr-2021 | Later Stage VC | 00.000 | Wireless Communications Equipment | Generating Revenue/Not Profitable | 00000 00000 00.0 |
| QuantalX | 26-Apr-2021 | Later Stage VC | 00.00 | Other Healthcare Technology Systems | Generating Revenue |
NetScientific Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| PDS Biotechnology | 15-Jun-2021 | Public Investment 2nd Offering | 000.00 |
| 00000 | 17-Mar-2019 | 0000000000 | |
| 0000000 000000 | 01-Jun-2018 | 000 00 00000000 | |
| 00000 000 0000 | 20-Apr-2018 | 000 | 000.00 |
| 00000000 | 30-Jun-2017 | 000 00 00000000 | |
| 00000000 | 31-Dec-2016 | 000000000000000000 | 00.00 |
| 00000000 000000000 | 18-Sep-2015 | 000000000 00000000 | 00.000 |
| 00000000000000 | 07-Aug-2015 | 0000000000 | |
| QuantaSol | 14-Jul-2011 | Merger/Acquisition | 00.00 |
| Aldwych 2011 | 07-Jul-2011 | Merger/Acquisition | 00.00 |
NetScientific Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
NetScientific Team (31)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Ian Postlethwaite | Chief Executive Officer | 0 | 0 | London, United Kingdom | |
| Stephen Crowe | Chief Financial Officer | London, United Kingdom | |||
| Kevin Dean | Venture Partner | London, United Kingdom | |||
| Charles Laughton | Associate Director of Corporate Finance | 0 | London, United Kingdom | ||
| Mark Nanovich | Finance Director | London, United Kingdom |
NetScientific Co-Investors (16)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| EMV Capital | 4 | 0 |
|
|
|
| Cetromed | 0 | 0 |
|
|
|
| Keiretsu Forum | 0 |
|
|
||
| Kelvin Capital | 0 | 0 |
|
|
|
| Scottish Enterprise | 0 | 0 |
|
|